Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to -$1.8 million.

  • Ascendis Pharma A's Exchange Rate Effect fell 118800.23% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.6 million, marking a year-over-year decrease of 48478.34%. This contributed to the annual value of $24.6 million for FY2024, which is 93875.55% up from last year.
  • Per Ascendis Pharma A's latest filing, its Exchange Rate Effect stood at -$1.8 million for Q3 2025, which was down 118800.23% from -$1.6 million recorded in Q2 2025.
  • Ascendis Pharma A's 5-year Exchange Rate Effect high stood at $41.0 million for Q4 2021, and its period low was -$9.0 million during Q1 2025.
  • Over the past 5 years, Ascendis Pharma A's median Exchange Rate Effect value was $92728.9 (recorded in 2021), while the average stood at $3.0 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Exchange Rate Effect surged by 146766.74% in 2021, and later plummeted by 990363.14% in 2025.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Exchange Rate Effect stood at $41.0 million in 2021, then tumbled by 94.49% to $2.3 million in 2022, then tumbled by 171.45% to -$1.6 million in 2023, then soared by 155.03% to $886934.1 in 2024, then tumbled by 307.47% to -$1.8 million in 2025.
  • Its Exchange Rate Effect stands at -$1.8 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$9.0 million for Q1 2025.